Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Open accessThe DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.
Abstract
The convergence of advances in medical science, human biology, data science, and technology has enabled the generation of new insights into the phenotype known as "diabetes." Increased knowledge of this condition has emerged from populations around the world, illuminating the differences in how diabetes presents, its variable prevalence, and how best practice in treatment varies between populations. In parallel, focus has been placed on the development of tools for the application of precision medicine to numerous conditions. This Consensus Report presents the American Diabetes Association (ADA) Precision Medicine in Diabetes Initiative in partnership with the European Association for the Study of Diabetes (EASD), including its mission, the current state of the field, and prospects for the future. Expert opinions are presented on areas of precision diagnostics and precision therapeutics (including prevention and treatment), and key barriers to and opportunities for implementation of precision diabetes medicine, with better care and outcomes around the globe, are highlighted. Cases where precision diagnosis is already feasible and effective (i.e., monogenic forms of diabetes) are presented, while the major hurdles to the global implementation of precision diagnosis of complex forms of diabetes are discussed. The situation is similar for precision therapeutics, in which the appropriate therapy will often change over time owing to the manner in which diabetes evolves within individual patients. This Consensus Report describes a foundation for precision diabetes medicine, while highlighting what remains to be done to realize its potential. This, combined with a subsequent, detailed evidence-based review (due 2022), will provide a roadmap for precision medicine in diabetes that helps improve the quality of life for all those with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the genetics of type 2 diabetes are poorly understood and under intense investigation in this era of precision medicine (52).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Self-citationGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
Herold, K. C., Bundy, B. N., Long, S. A., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1902226 · Cited by 1,189
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationEffect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Self-citationType 1 Diabetes Genetics Consortium, Onengut-Gumuscu, S., Chen, W.-M., Burren, O., Cooper, N. J., Quinlan, A. R., Mychaleckyj, J. C., Farber, E., Bonnie, J. K., Szpak, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3245 · Cited by 680
The link between depression and diabetes: the search for shared mechanisms
Moulton, C. D., Pickup, J. C., & Ismail, K. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00134-5 · Cited by 670
Activating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus
Babenko, A. P., Polak, M., Cavé, H., Busiah, K., Czernichow, P., Scharfmann, R., Bryan, J., Aguilar-Bryan, L., Vaxillaire, M., & Froguel, P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055068 · Cited by 655
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationZaharia, O. P., Strassburger, K., Strom, A., Bönhof, G. J., Karusheva, Y., Antoniou, S., Bódis, K., Markgraf, D. F., Burkart, V., Müssig, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30187-1 · Cited by 600
Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., & Mackay, I. R. (1993) · Diabetes · doi:10.2337/diab.42.2.359 · Cited by 581
Kilpeläinen, T. O., Qi, L., Brage, S., Sharp, S. J., Sonestedt, E., Demerath, E., Ahmad, T., Mora, S., Kaakinen, M., Sandholt, C. H., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001116 · Cited by 559
Udler, M. S., Kim, J., von Grotthuss, M., Bonàs-Guarch, S., Cole, J. B., Chiou, J., ISGC, C. D. A. O. B. O. M. A. T., Boehnke, M., Laakso, M., Atzmon, G., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002654 · Cited by 542
Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15786-3 · Cited by 534
Aroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3761 · Cited by 467
Dennis, J. M., Shields, B. M., Henley, W. E., Jones, A. G., & Hattersley, A. T. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30087-7 · Cited by 462
Constructs of depression and distress in diabetes: time for an appraisal
Snoek, F. J., Bremmer, M. A., & Hermanns, N. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00135-7 · Cited by 449
Mahajan, A., Wessel, J., Willems, S. M., Zhao, W., Robertson, N. R., Chu, A. Y., Gan, W., Kitajima, H., Taliun, D., Rayner, N. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0084-1 · Cited by 442
Self-citationCommon variants near ATM are associated with glycemic response to metformin in type 2 diabetes
The GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group, & The Wellcome Trust Case Control Consortium 2 (2011) · Nature Genetics · doi:10.1038/ng.735 · Cited by 432
Thomas, N. J., Jones, S. E., Weedon, M. N., Shields, B. M., Oram, R. A., & Hattersley, A. T. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30362-5 · Cited by 417
Self-citationKim, Y. G., Hahn, S., Oh, T. J., Kwak, S. H., Park, K. S., & Cho, Y. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2827-3 · Cited by 396
Näntö-Salonen, K., Kupila, A., Simell, S., Siljander, H., Salonsaari, T., Hekkala, A., Korhonen, S., Erkkola, R., Sipilä, J. I., Haavisto, L., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61309-4 · Cited by 382
Steele, A. M., Shields, B. M., Wensley, K. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · JAMA · doi:10.1001/jama.2013.283980 · Cited by 381
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Sharp, S. A., Rich, S. S., Wood, A. R., Jones, S. E., Beaumont, R. N., Harrison, J. W., Schneider, D. A., Locke, J. M., Tyrrell, J., Weedon, M. N., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1785 · Cited by 366
Self-citationHaw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354
HNF1B-associated renal and extra-renal disease—an expanding clinical spectrum
Clissold, R. L., Hamilton, A. J., Hattersley, A. T., Ellard, S., & Bingham, C. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.232 · Cited by 352
Battaglia, M., Ahmed, S., Anderson, M. S., Atkinson, M. A., Becker, D., Bingley, P. J., Bosi, E., Brusko, T. M., DiMeglio, L. A., Evans-Molina, C., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0880 · Cited by 351
De Franco, E., Flanagan, S. E., Houghton, J. A., Allen, H. L., Mackay, D. J., Temple, I. K., Ellard, S., & Hattersley, A. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60098-8 · Cited by 349
Self-citationOram, R. A., Patel, K., Hill, A., Shields, B., McDonald, T. J., Jones, A., Hattersley, A. T., & Weedon, M. N. (2016) · Diabetes Care · doi:10.2337/dc15-1111 · Cited by 349
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
Hawa, M. I., Kolb, H., Schloot, N., Beyan, H., Paschou, S. A., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Beck-Neilsen, H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0931 · Cited by 339
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s005 · Cited by 339
Shields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., & Hattersley, A. T. (2012) · Diabetologia · doi:10.1007/s00125-011-2418-8 · Cited by 335
Permanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2
Sagen, J. V., Ræder, H., Hathout, E., Shehadeh, N., Gudmundsson, K., Bævre, H., Abuelo, D., Phornphutkul, C., Molnes, J., Bell, G. I., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2713 · Cited by 333
Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults
Graff, M., Scott, R. A., Justice, A. E., Young, K. L., Feitosa, M. F., Barata, L., Winkler, T. W., Chu, A. Y., Mahajan, A., Hadley, D., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006528 · Cited by 329
Precision diabetes: learning from monogenic diabetes
Hattersley, A. T., & Patel, K. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4226-2 · Cited by 306
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
Udler, M. S., McCarthy, M. I., Florez, J. C., & Mahajan, A. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00088 · Cited by 302
Self-citationMurphy, R., Turnbull, D. M., Walker, M., & Hattersley, A. T. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02359.x · Cited by 291
Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas
Pearson, E. R., Donnelly, L. A., Kimber, C., Whitley, A., Doney, A. S. F., McCarthy, M. I., Hattersley, A. T., Morris, A. D., & Palmer, C. N. A. (2007) · Diabetes · doi:10.2337/db07-0440 · Cited by 286
Addressing diabetes distress in clinical care: A practical guide
Fisher, L., Polonsky, W. H., & Hessler, D. (2019) · Diabetic Medicine · doi:10.1111/dme.13967 · Cited by 273
Jablonski, K. A., McAteer, J. B., de Bakker, P. I. W., Franks, P. W., Pollin, T. I., Hanson, R. L., Saxena, R., Fowler, S., Shuldiner, A. R., Knowler, W. C., et al. (2010) · Diabetes · doi:10.2337/db10-0543 · Cited by 271
Self-citationDiabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2518 · Cited by 262
The Diabetes Prevention Program Research Group [Prepared by Jill Crandall, D. S. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1075 · Cited by 254
Powe, C. E., Allard, C., Battista, M.-C., Doyon, M., Bouchard, L., Ecker, J. L., Perron, P., Florez, J. C., Thadhani, R., & Hivert, M.-F. (2016) · Diabetes Care · doi:10.2337/dc15-2672 · Cited by 240
Gene-Lifestyle Interaction and Type 2 Diabetes: The EPIC InterAct Case-Cohort Study
Langenberg, C., Sharp, S. J., Franks, P. W., Scott, R. A., Deloukas, P., Forouhi, N. G., Froguel, P., Groop, L. C., Hansen, T., Palla, L., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001647 · Cited by 237
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
MetGen Investigators, Zhou, K., DPP Investigators, ACCORD Investigators, Yee, S. W., Seiser, E. L., van Leeuwen, N., Tavendale, R., Bennett, A. J., Groves, C. J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3632 · Cited by 234
Pearson, E. R., Pruhova, S., Tack, C. J., Johansen, A., Castleden, H. A. J., Lumb, P. J., Wierzbicki, A. S., Clark, P. M., Lebl, J., Pedersen, O., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1738-y · Cited by 232
12. Older Adults:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s012 · Cited by 223
Hummel, S., Pflüger, M., Hummel, M., Bonifacio, E., & Ziegler, A.-G. (2011) · Diabetes Care · doi:10.2337/dc10-2456 · Cited by 218
Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group, Krischer, J. P., Schatz, D. A., Bundy, B., Skyler, J. S., & Greenbaum, C. J. (2017) · JAMA · doi:10.1001/jama.2017.17070 · Cited by 214
Stride, A., Shields, B., Gill-Carey, O., Chakera, A. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · Diabetologia · doi:10.1007/s00125-013-3075-x · Cited by 212
Gene–obesogenic environment interactions in the UK Biobank study
Tyrrell, J., Wood, A. R., Ames, R. M., Yaghootkar, H., Beaumont, R. N., Jones, S. E., Tuke, M. A., Ruth, K. S., Freathy, R. M., Davey Smith, G., et al. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw337 · Cited by 208
The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
Lampeter, E. F., Klinghammer, A., Scherbaum, W. A., Heinze, E., Haastert, B., Giani, G., & Kolb, H. (1998) · Diabetes · doi:10.2337/diabetes.47.6.980 · Cited by 196
Hivert, M.-F., Jablonski, K. A., Perreault, L., Saxena, R., McAteer, J. B., Franks, P. W., Hamman, R. F., Kahn, S. E., Haffner, S., the DIAGRAM Consortium, et al. (2011) · Diabetes · doi:10.2337/db10-1119 · Cited by 191
Self-citationZhou, K., Donnelly, L. A., Kimber, C. H., Donnan, P. T., Doney, A. S. F., Leese, G., Hattersley, A. T., McCarthy, M. I., Morris, A. D., Palmer, C. N. A., et al. (2009) · Diabetes · doi:10.2337/db08-0896 · Cited by 184
Thomas, N. J., Lynam, A. L., Hill, A. V., Weedon, M. N., Shields, B. M., Oram, R. A., McDonald, T. J., Hattersley, A. T., & Jones, A. G. (2019) · Diabetologia · doi:10.1007/s00125-019-4863-8 · Cited by 183
Heterozygous ABCC8 mutations are a cause of MODY
Bowman, P., Flanagan, S. E., Edghill, E. L., Damhuis, A., Shepherd, M. H., Paisey, R., Hattersley, A. T., & Ellard, S. (2012) · Diabetologia · doi:10.1007/s00125-011-2319-x · Cited by 177
Bowman, P., Sulen, Å., Barbetti, F., Beltrand, J., Svalastoga, P., Codner, E., Tessmann, E. H., Juliusson, P. B., Skrivarhaug, T., Pearson, E. R., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30106-2 · Cited by 175
Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4961-7 · Cited by 168
Hydrolyzed Infant Formula and Early β-Cell Autoimmunity: A Randomized Clinical Trial
Knip, M., Åkerblom, H. K., Becker, D., Dosch, H.-M., Dupre, J., Fraser, W., Howard, N., Ilonen, J., Krischer, J. P., Kordonouri, O., et al. (2014) · JAMA · doi:10.1001/jama.2014.5610 · Cited by 167
Depression and diabetes: Treatment and health-care delivery
Petrak, F., Baumeister, H., Skinner, T. C., Brown, A., & Holt, R. I. G. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00045-5 · Cited by 166
Zhou, K., Donnelly, L., Burch, L., Tavendale, R., Doney, A. S. F., Leese, G., Hattersley, A. T., McCarthy, M. I., Morris, A. D., Lang, C. C., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.176 · Cited by 161
Feng, Y., Mao, G., Ren, X., Xing, H., Tang, G., Li, Q., Li, X., Sun, L., Yang, J., Ma, W., et al. (2008) · Diabetes Care · doi:10.2337/dc07-2248 · Cited by 156
Apolzan, J. W., Venditti, E. M., Edelstein, S. L., Knowler, W. C., Dabelea, D., Boyko, E. J., Pi-Sunyer, X., Kalyani, R. R., Franks, P. W., Srikanthan, P., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1605 · Cited by 156
Self-citationWriting Group for the TRIGR Study Group, Knip, M., Åkerblom, H. K., Al Taji, E., Becker, D., Bruining, J., Castano, L., Danne, T., de Beaufort, C., Dosch, H.-M., et al. (2018) · JAMA · doi:10.1001/jama.2017.19826 · Cited by 154
Hao, W., Gitelman, S., DiMeglio, L. A., Boulware, D., Greenbaum, C. J., & for the Type 1 Diabetes TrialNet Study Group (2016) · Diabetes Care · doi:10.2337/dc16-0360 · Cited by 150
Hayes, M. G., Urbanek, M., Hivert, M.-F., Armstrong, L. L., Morrison, J., Guo, C., Lowe, L. P., Scheftner, D. A., Pluzhnikov, A., Levine, D. M., et al. (2013) · Diabetes · doi:10.2337/db12-1692 · Cited by 143
Livingstone, K. M., Celis-Morales, C., Papandonatos, G. D., Erar, B., Florez, J. C., Jablonski, K. A., Razquin, C., Marti, A., Heianza, Y., Huang, T., et al. (2016) · BMJ · doi:10.1136/bmj.i4707 · Cited by 141
Spyer, G., Macleod, K. M., Shepherd, M., Ellard, S., & Hattersley, A. T. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02622.x · Cited by 130
Onengut-Gumuscu, S., Chen, W.-M., Robertson, C. C., Bonnie, J. K., Farber, E., Zhu, Z., Oksenberg, J. R., Brant, S. R., Bridges, S. L., Edberg, J. C., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1727 · Cited by 128
Vaarala, O., Ilonen, J., Ruohtula, T., Pesola, J., Virtanen, S. M., Härkönen, T., Koski, M., Kallioinen, H., Tossavainen, O., Poussa, T., et al. (2012) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2011.1559 · Cited by 127
Delahanty, L. M., Pan, Q., Jablonski, K. A., Aroda, V. R., Watson, K. E., Bray, G. A., Kahn, S. E., Florez, J. C., Perreault, L., Franks, P. W., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0018 · Cited by 125
Self-citationFleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetologia · doi:10.1007/s00125-019-05034-1 · Cited by 125
A Global Overview of Precision Medicine in Type 2 Diabetes
Fitipaldi, H., McCarthy, M. I., Florez, J. C., & Franks, P. W. (2018) · Diabetes · doi:10.2337/dbi17-0045 · Cited by 122
Shields, B. M., McDonald, T. J., Oram, R., Hill, A., Hudson, M., Leete, P., Pearson, E. R., Richardson, S. J., Morgan, N. G., Hattersley, A. T., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0465 · Cited by 120
Long-Term Outcome of Individuals Treated With Oral Insulin
Vehik, K., Cuthbertson, D., Ruhlig, H., Schatz, D. A., Peakman, M., Krischer, J. P., & Groups, F. T. D.-1. A. T. S. (2011) · Diabetes Care · doi:10.2337/dc11-0523 · Cited by 117
KANG, E., PARK, S., KIM, H., KIM, C., AHN, C., CHA, B., LIM, S., NAM, C., & LEE, H. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.04.013 · Cited by 117
High residual C-peptide likely contributes to glycemic control in type 1 diabetes
Rickels, M. R., Evans-Molina, C., Bahnson, H. T., Ylescupidez, A., Nadeau, K. J., Hao, W., Clements, M. A., Sherr, J. L., Pratley, R. E., Hannon, T. S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134057 · Cited by 113
Carlsson, A., Shepherd, M., Ellard, S., Weedon, M., Lernmark, Å., Forsander, G., Colclough, K., Brahimi, Q., Valtonen-Andre, C., Ivarsson, S. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0747 · Cited by 111
Somatic hypermutation of an immunoglobulin transgene in K transgenic mice
O’Brien, R. L., Brinster, R. L., & Storb, U. (1987) · Nature · doi:10.1038/326405a0 · Cited by 109
Genetics of Gestational Diabetes Mellitus and Maternal Metabolism
Lowe, W. L., Scholtens, D. M., Sandler, V., & Hayes, M. G. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0709-z · Cited by 108
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐Analysis
Dujic, T., Zhou, K., Yee, S., van Leeuwen, N., de Keyser, C., Javorský, M., Goswami, S., Zaharenko, L., Hougaard Christensen, M., Out, M., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.567 · Cited by 108
Standardization of C-peptide measurements
Little, R. R., Rohlfing, C. L., Tennill, A. L., Madsen, R. W., Polonsky, K. S., Myers, G. L., Greenbaum, C. J., Palmer, J. P., Rogatsky, E., & Stein, D. T. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101287 · Cited by 103
Sundelin, E., Gormsen, L., Jensen, J., Vendelbo, M., Jakobsen, S., Munk, O., Christensen, M., Brøsen, K., Frøkiær, J., & Jessen, N. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.701 · Cited by 100
KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
Javorský, M., Klimčáková, L., Schroner, Z., Židzik, J., Babjaková, E., Fabianová, M., Kozárová, M., Tkáčová, R., Salagovic, J., & Tkáč, I. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.10.018 · Cited by 98
Differing Effects of Metformin on Glycemic Control by Race-Ethnicity
Williams, L. K., Padhukasahasram, B., Ahmedani, B. K., Peterson, E. L., Wells, K. E., González Burchard, E., & Lanfear, D. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1539 · Cited by 95
Dennis, J. M., Shields, B. M., Hill, A. V., Knight, B. A., McDonald, T. J., Rodgers, L. R., Weedon, M. N., Henley, W. E., Sattar, N., Holman, R. R., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1827 · Cited by 92
Papandonatos, G. D., Pan, Q., Pajewski, N. M., Delahanty, L. M., Peter, I., Erar, B., Ahmad, S., Harden, M., Chen, L., Fontanillas, P., et al. (2015) · Diabetes · doi:10.2337/db15-0441 · Cited by 88
Self-citationTime to Insulin Initiation Cannot Be Used in Defining Latent Autoimmune Diabetes in Adults
Brophy, S., Yderstræde, K., Mauricio, D., Hunter, S., Hawa, M., Pozzilli, P., Schernthaner, G., Schoot, N., Buzzetti, R., Davies, H., et al. (2008) · Diabetes Care · doi:10.2337/dc07-1308 · Cited by 79
Schroner, Z., Javorsky, M., Tkacova, R., Klimcakova, L., Dobrikova, M., Habalova, V., Kozarova, M., Zidzik, J., Rudikova, M., & Tkac, I. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01324.x · Cited by 77
Dawed, A. Y., Donnelly, L. A., Tavendale, R., Carr, F., Leese, G., Palmer, C. N. A., Pearson, E. R., & Zhou, K. (2016) · Diabetes Care · doi:10.2337/dc15-2464 · Cited by 76
Zhang, H., Liu, X.-M., Kuang, H., Yi, R., & Xing, H. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.021 · Cited by 74
Godino, J. G., van Sluijs, E. M. F., Marteau, T. M., Sutton, S., Sharp, S. J., & Griffin, S. J. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002185 · Cited by 72
Busaidi, N. A., Shanmugam, P., & Manoharan, D. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1125-6 · Cited by 72
Enteroviral pathogenesis of type 1 diabetes: queries and answers
Hober, D., & Alidjinou, E. K. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283608300 · Cited by 70
Hsieh, M., Lin, K., Tien, K., Tu, S., Hsiao, J., Chang, S., Lin, S., Shing, S.-J., & Chen, H. (2010) · Metabolism · doi:10.1016/j.metabol.2009.10.030 · Cited by 68
The use of intermediate endpoints in the design of type 1 diabetes prevention trials
the Type 1 Diabetes TrialNet Study Group, & Krischer, J. P. (2013) · Diabetologia · doi:10.1007/s00125-013-2960-7 · Cited by 64
Elding Larsson, H., Lundgren, M., Jonsdottir, B., Cuthbertson, D., Krischer, J., & for the DiAPREV‐IT Study Group (2018) · Pediatric Diabetes · doi:10.1111/pedi.12611 · Cited by 63
Pei, Q., Huang, Q., Yang, G.-P., Zhao, Y., Yin, J., Song, M., Zheng, Y., Mo, Z., Zhou, H. H., & Liu, Z. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.144 · Cited by 61
Tapia, G., Mårild, K., Dahl, S. R., Lund‐Blix, N. A., Viken, M. K., Lie, B. A., Njølstad, P. R., Joner, G., Skrivarhaug, T., Cohen, A. S., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2176 · Cited by 61
Grubb, A. L., McDonald, T. J., Rutters, F., Donnelly, L. A., Hattersley, A. T., Oram, R. A., Palmer, C. N. A., van der Heijden, A. A., Carr, F., Elders, P. J. M., et al. (2019) · Diabetes Care · doi:10.2337/dc18-0431 · Cited by 50
Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients
Vandemeulebroucke, E., Gorus, F., Decochez, K., Weets, I., Keymeulen, B., Block, C. E. M. D., Tits, J., PIPELEERS, D. G., & Mathieu, C. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.02.005 · Cited by 47
Norris, J. M., Kroehl, M., Fingerlin, T. E., Frederiksen, B. N., Seifert, J., Wong, R., Clare-Salzler, M., & Rewers, M. (2014) · Diabetologia · doi:10.1007/s00125-013-3106-7 · Cited by 43
Hakola, L., Takkinen, H.-M., Niinistö, S., Ahonen, S., Nevalainen, J., Veijola, R., Ilonen, J., Toppari, J., Knip, M., & Virtanen, S. M. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwx191 · Cited by 42
Hivert, M.-F., Christophi, C. A., Franks, P. W., Jablonski, K. A., Ehrmann, D. A., Kahn, S. E., Horton, E. S., Pollin, T. I., Mather, K. J., Perreault, L., et al. (2016) · Diabetes · doi:10.2337/db15-0950 · Cited by 38
Self-citationPoudel, A., Zhou, J. Y., Story, D. T., & Li, L. (2018) · Journal of Diabetes Research · doi:10.1155/2018/2742565 · Cited by 38
Ellard, S., Colclough, K., Patel, K. A., & Hattersley, A. T. (2019) · Journal of Clinical Investigation · doi:10.1172/jci133516 · Cited by 38
Association betweenTCF7L2Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide
Javorský, M., Babjaková, E., Klimčáková, L., Schroner, Z., Židzik, J., Štolfová, M., Salagovic, J., & Tkáč, I. (2013) · International Journal of Endocrinology · doi:10.1155/2013/374858 · Cited by 34
Monogenic diabetes in adults: what are the new developments?
Owen, K. R. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.04.006 · Cited by 34
Prediction and Prevention of Type 2 Diabetes in Women with a History of GDM
Tobias, D. K. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1063-8 · Cited by 33
De Franco, E., Caswell, R., Houghton, J. A. L., Iotova, V., Hattersley, A. T., & Ellard, S. (2017) · Diabetic Medicine · doi:10.1111/dme.13180 · Cited by 31
Davis, T. M. E., Mulder, H. S., Lokhnygina, Y. V., Aschner, P. J., Chuang, L., Grado, C. A. R., Standl, E., Peterson, E. D., Holman, R. R., & for the TECOS Study Group (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13242 · Cited by 31
Dennis, J., Shields, B. M., Jones, A. G., Pearson, E. R., Hattersley, A. T., & Henley, W. (2018) · Clinical Epidemiology · doi:10.2147/clep.s179555 · Cited by 29
Genetics and its potential to improve type 1 diabetes care
Rich, S. S. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000347 · Cited by 27
Economics of Genetic Testing for Diabetes
Naylor, R. N. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1140-7 · Cited by 25
Shungin, D., Deng, W. Q., Varga, T. V., Luan, J., Mihailov, E., Metspalu, A., Morris, A. P., Forouhi, N. G., Lindgren, C. M., Magnusson, P. K. E., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006812 · Cited by 24
GCK-MODY in the US Monogenic Diabetes Registry: description of 27 unpublished variants
Sanyoura, M., Letourneau, L., Knight Johnson, A. E., del Gaudio, D., Greeley, S. A. W., Philipson, L. H., & Naylor, R. N. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.04.017 · Cited by 23
Self-citationCooray, S. D., Boyle, J. A., Soldatos, G., Wijeyaratne, L. A., & Teede, H. J. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1151-0 · Cited by 21
Shepherd, M. H., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-2-117 · Cited by 20
Gupta, R. D., Gupta, S., Das, A., Biswas, T., Haider, M. R., & Sarker, M. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1471354 · Cited by 15
Precision Medicine, Diabetes, and the U.S. Food and Drug Administration
Meyer, R. J. (2016) · Diabetes Care · doi:10.2337/dc16-1762 · Cited by 14
Skyler, J. S. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_15-1 · Cited by 4
WFS1 Wolfram Syndrome Spectrum Disorder -- GeneReviews®
Adam, M. P., Hh, A., Ra, P., Se, W., Ljh, B., Stephens, K. D., & Amemiya, A. (2020) · Cited by 2
Research works printed but not linked: 1
- Rewers M, Stene LC, Norris JM Chapter 11: Risk factors for type 1 diabetes. In Diabetes in America, 3rd ed Cowie CC, Casagrande SS, Menke A,, Eds. Bethesda, MD, National Institutes of Health, 2018
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Metadata
- Authors
- Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., Philipson, L., McElvaine, A. T., Cefalu, W. T., Rich, S. S., & Franks, P. W.
- Affiliations
- Columbia University Irving Medical Center (US)
- American Diabetes Association (US)
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA
- University of Exeter (GB)
- Harvard University (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Centre for Human Genetics (GB)
- Trinity College Dublin (IE)
- Colorado School of Public Health (US)
- University of Dundee (GB)
- University of Chicago (US)
- Duke University (US)
- University of Virginia (US)
- Corresponding author
- Franks, Paul W.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-06-11
- Volume
- 43
- Issue
- 7
- Pages
- 1617-1635
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7305007
- OpenAlex
- W3036199105
- Cited by
- 400
- References
- 136
- Citations by year
- 2026: 50 · 2025: 57 · 2024: 74 · 2023: 92 · 2022: 72 · 2021: 47 · 2020: 8
- FWCI
- 41.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, public-domain)
- Funders
- American Diabetes Association (1-15-ACE-26)
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Regeneron Pharmaceuticals
- Wellcome Trust (212259, 098381, 098395, 098395/Z/12/Z, 203141, 102820/Z/13/Z)
- National Institute for Health and Care Research (NF-SI-0611-10219, NF-SI-0617-10090)
- European Commission (115317, 115881, 875534, 098381)
- Lunds Universitet
- Novo Nordisk
- Vetenskapsrådet
- Universitetet i Bergen
- Servier
- National Institutes of Health (5r21ai142483-02, DK26687, UL1TR001873)
- Genentech
- Medical Research Council (MR/K005707/1, MR/T032014/1)
- National Institute of Allergy and Infectious Diseases (R21-AI142483)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-26687, R01DK104942, 212259, R01DK052431, R01DK122586, U01DK105535, DP3DK111906, DK 26687, DK104351, R01DK104351, DK122586, 098381, 203141, P30DK026687, U54DK118612, P30DK020595, DK-52431)
- National Center for Advancing Translational Sciences
- Janssen Pharmaceuticals
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD094150)
- University of Colorado School of Medicine, Anschutz Medical Campus
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- precision medicine, diabetes mellitus, precision diagnostics, precision therapy, monogenic diabetes, diabetes prevention, diabetes treatment, implementation barriers, personalized medicine, diabetes phenotypes
- MeSH terms
- Diabetes Mellitus, Endocrinology, Europe, Financial Management, Health Plan Implementation, Humans, Practice Patterns, Physicians', Quality of Life, Societies, Medical, United States, Evidence-Based Medicine, Consensus, Biomedical Research, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.